SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

Infinite Money Glitch ($IMG) is trending as its community celebrates a one-year anniversary, emphasizing the token's resilience and continuous building while highlighting its core utility of consistent passive Solana rewards. Ongoing discussions center on the newly activated incinerator and liquidity pool features, solidifying the 'glitch' narrative of financial freedom for holders.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

Anavex Life Sciences is trending amidst strong community speculation around an imminent European regulatory re-examination decision for its Alzheimer's drug, Blarcamesine, particularly for genetically defined patient subgroups, contrasting its oral convenience and safety profile against existing high-cost mAb treatments. This comes as investors also monitor upcoming financial updates and the strategic implications of a new board appointment for the company's European market penetration.

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals is trending amidst strong reports of OJEMDA revenue growth and raised 2026 guidance, amplified by its strategic acquisition of Mersana Therapeutics' ADC pipeline. This has ignited fervent community speculation about a potential buyout, especially given the company's robust cash position and recent analyst price target increases in an active biotech M&A landscape.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending amidst a general crypto market uplift, sparking community debate about whether the current movement signals a true alt season breakout or is merely another fleeting pump-and-dump. Renewed speculation regarding its potential integration into Elon Musk's X platform continues to heavily influence sentiment.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is buzzing after its Morgan Stanley conference, where management painted a bullish picture of accelerated progress in advanced manufacturing, AI-native 6G initiatives, and anticipated billion-dollar foundry and packaging deals. The community sees Intel as a potentially undervalued turnaround story, especially with rumors of Nvidia and MediaTek leveraging its capabilities.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending amidst a fervent debate, with many in the community anticipating a significant rally fueled by technical indicators and potential institutional interest, while a vocal contingent expresses frustration over its historical underperformance compared to other digital assets.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is trending heavily ahead of its upcoming Q4 earnings report, with community sentiment dominated by deep frustration over its continued decline to multi-year lows despite seemingly strong underlying financials and substantial cash reserves, while many criticize management's perceived inaction on share buybacks.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is experiencing extreme volatility and high trading volume, largely fueled by escalating Middle East geopolitical tensions threatening global oil supply routes and a recent significant private placement. The community is sharply divided between those anticipating further short-squeeze driven gains due to supply concerns, and others warning of a pump-and-dump, citing a recent offering at a substantially lower price point and the company's considerable debt.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is a hot topic after its substantial 2026 revenue and profitability guidance, which bulls view as a sign of undervaluation and strong execution, while bears remain skeptical due to recent earnings misses and the challenging Affordable Care Act market.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom (AVGO) is seeing intense community discussion leading up to its earnings report, with much speculation focusing on whether anticipated strong AI revenue growth from custom chips and networking can overcome concerns about margin compression and recent volatile reactions in the broader semiconductor sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$RGBP  Ring** 
Thanks for calling RGBP.  
How can I help you?  
 
Hi, first time caller, long time skeptic. 
Just curious. 
What legitimate thing has David Koos ever done? 
 
Oh now that&#39;s a great question. 
Let&#39;s see... 
He promised Hemaxelerate would be in clinicals 12 years ago.  
But yeah that didn&#39;t happen so never mind.  
He did two licensing deals with his own companies. 
Nevermind again. 
He did 2 license deals with a criminal biopharma ONPH.  
Nevermind. 
He wrote a big long message to the shareholders promising no more convertible debt. 
Yeah nevermind that too. 
He promised that we&#39;re putting Duracar into clinicals. 
Again... Nevermind. 
Tell you what. 
How about you give me your phone number and if he ever does anything legitimate I&#39;ll give you a call. 
Have a nice day. 
**Click** 
🧚

Roger Waters

Guy renfro

Margie I Guess

Sam. P

Kelly Smith

Dan Sim

Clifford Koos

Richard Leist

StockTwits Web

Regen Biopharma Inc

  Ring** 
Thanks for calling RGBP.  
How can I help you?  
 
Hi, first time caller, long time skeptic. 
Just curious. 
What legitimate thing has David Koos ever done? 
 
Oh now that's a great question. 
Let's see... 
He promised Hemaxelerate would be in clinicals 12 years ago.  
But yeah that didn't happen so never mind.  
He did two licensing deals with his own companies. 
Nevermind again. 
He did 2 license deals with a criminal biopharma ONPH.  
Nevermind. 
He wrote a big long message to the shareholders promising no more convertible debt. 
Yeah nevermind that too. 
He promised that we're putting Duracar into clinicals. 
Again... Nevermind. 
Tell you what. 
How about you give me your phone number and if he ever does anything legitimate I'll give you a call. 
Have a nice day. 
**Click** 
🧚

@TrippinStones 
I see you’re having fun being a bear. Good post, good facts, good sense. However, the spark is not out. Rand just bought 300k shares because he believes Koos can deliver. 

Too big of a gamble for me but I hope it pays off for them. Out of stubbornness I’m still holding my shares.

Kasmat

Clifford George

StockTwits for iOS

 
I see you’re having fun being a bear. Good post, good facts, good sense. However, the spark is not out. Rand just bought 300k shares because he believes Koos can deliver. 

Too big of a gamble for me but I hope it pays off for them. Out of stubbornness I’m still holding my shares.